Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Nagarani G, et al.
Published in Heliyon
Abstract
GRADE-assessed systematic review and meta-analysis of Momordica charantia supplementation in type 2 diabetes.
Key Findings
Pooled results suggested a small reduction in fasting blood glucose with M. charantia but no significant change in HbA1c or lipid profile, with GRADE certainty rated low.
Conclusions
Any glycemic benefit is small and not supported by durable HbA1c change.
Limitations
Low-certainty evidence, heterogeneous preparations and doses.
Supplements Studied
Pooled results suggested a small reduction in fasting blood glucose with M. charantia but no significant change in HbA1c or lipid profile, with GRADE certainty rated low.
Outcomes Measured
Pooled results suggested a small reduction in fasting blood glucose with M. charantia but no significant change in HbA1c or lipid profile, with GRADE certainty rated low.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.